"but a STRONG assumption (expectation) is that AHA will be the likely delivery of FLD (good or bad), correct?"

Yes, AHA will be where the detailed data for the primary endpoint of BETonMACE will be delivered. Primary endpoint is:  Time to first occurrence of adjudication-confirmed narrowly defined MACE (single composite endpoint of CV death or non-fatal MI or stroke).

However, keep in mind that there are many secondary and exploratory endpoints as well as the CKD and cognition sub-studies, as well as pre-specified sub-group comparisons for the primary endpoint. See this post. Very unlikely that ALL of these will be presented at the AHA late-breaking session or even in the first BETonMACE published report. AHA will only be the beginning.

BearDownAZ